Fraaij PL - Search Results

1

Priority Needs for Conducting Pandemic-relevant Clinical Research With Children in Europe: A Consensus Study With Pediatric Clinician-researchers.

Gal M, Gobat N, Francis NA, Hood K, Butler CC, Bielicki J, Fraaij PL, Sharland M, Jarvis J, van Rossum AMC, Heikkinen T, Martinon-Torres F, Herberg J, Watkins A, Webb SAR, Moore R, Sukumar P, Nichol A. Gal M, et al. Among authors: fraaij pl. Pediatr Infect Dis J. 2019 May;38(5):e82-e86. doi: 10.1097/INF.0000000000002204. Pediatr Infect Dis J. 2019. PMID: 30256315 Free article.

2

Efficacy of highly active antiretroviral therapy in HIV-1 infected children.

van Rossum AM, Fraaij PL, de Groot R. van Rossum AM, et al. Among authors: fraaij pl. Lancet Infect Dis. 2002 Feb;2(2):93-102. doi: 10.1016/s1473-3099(02)00183-4. Lancet Infect Dis. 2002. PMID: 11901656 Review.

3

Persistent sterile leukocyturia is associated with impaired renal function in human immunodeficiency virus type 1-infected children treated with indinavir.

van Rossum AM, Dieleman JP, Fraaij PL, Cransberg K, Hartwig NG, Burger DM, Gyssens IC, de Groot R. van Rossum AM, et al. Among authors: fraaij pl. Pediatrics. 2002 Aug;110(2 Pt 1):e19. doi: 10.1542/peds.110.2.e19. Pediatrics. 2002. PMID: 12165618 Free article.

4

Therapeutic drug monitoring of indinavir and nelfinavir to assess adherence to therapy in human immunodeficiency virus-infected children.

van Rossum AM, Bergshoeff AS, Fraaij PL, Hugen PW, Hartwig NG, Geelen SP, Wolfs TF, Weemaes CM, De Groot R, Burger DM. van Rossum AM, et al. Among authors: fraaij pl. Pediatr Infect Dis J. 2002 Aug;21(8):743-7. doi: 10.1097/00006454-200208000-00009. Pediatr Infect Dis J. 2002. PMID: 12192162 Clinical Trial.

5

Changes in indinavir exposure over time: a case study in six HIV-1-infected children.

Fraaij PL, Bergshoeff AS, van Rossum AM, Hartwig NG, Burger DM, de Groot R. Fraaij PL, et al. J Antimicrob Chemother. 2003 Oct;52(4):727-30. doi: 10.1093/jac/dkg391. Epub 2003 Aug 13. J Antimicrob Chemother. 2003. PMID: 12917234

6

A new method for analysis of AZT-triphosphate and nucleotide-triphosphates.

van Kampen JJ, Fraaij PL, Hira V, van Rossum AM, Hartwig NG, de Groot R, Luider TM. van Kampen JJ, et al. Among authors: fraaij pl. Biochem Biophys Res Commun. 2004 Feb 27;315(1):151-9. doi: 10.1016/j.bbrc.2004.01.032. Biochem Biophys Res Commun. 2004. PMID: 15013439

7

Safety and efficacy of a NRTI-sparing HAART regimen of efavirenz and lopinavir/ritonavir in HIV-1-infected children.

Fraaij PL, Neubert J, Bergshoeff AS, van Rossum AM, Hartwig NG, Schroten H, Korn K, Burger DM, de Groot R, Niehues T. Fraaij PL, et al. Antivir Ther. 2004 Apr;9(2):297-9. Antivir Ther. 2004. PMID: 15134193 Clinical Trial.

8

Sustained viral suppression and immune recovery in HIV type 1-infected children after 4 years of highly active antiretroviral therapy.

Fraaij PL, Verweel G, van Rossum AM, van Lochem EG, Schutten M, Weemaes CM, Hartwig NG, Burger DM, de Groot R. Fraaij PL, et al. Clin Infect Dis. 2005 Feb 15;40(4):604-8. doi: 10.1086/427696. Epub 2005 Jan 25. Clin Infect Dis. 2005. PMID: 15712085

9

Indinavir/low-dose ritonavir containing HAART in HIV-1 infected children has potent antiretroviral activity, but is associated with side effects and frequent discontinuation of treatment.

Fraaij PL, Verweel G, van Rossum AM, Hartwig NG, Burger DM, de Groot R. Fraaij PL, et al. Infection. 2007 Jun;35(3):186-9. doi: 10.1007/s15010-007-6068-1. Infection. 2007. PMID: 17565462 Free PMC article. Clinical Trial.

10

Seasonal influenza: the burden of disease in children.

Fraaij PL, Heikkinen T. Fraaij PL, et al. Vaccine. 2011 Oct 6;29(43):7524-8. doi: 10.1016/j.vaccine.2011.08.010. Epub 2011 Aug 4. Vaccine. 2011. PMID: 21820476 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

101 results

Search Page